Improving patient selection in Living-Donor Liver transplantation: Prognostication with pre-transplant 18-fluoro-deoxyglucose Positron Emission Tomography

Int J Surg. 2019 Dec:72:115-116. doi: 10.1016/j.ijsu.2019.10.038. Epub 2019 Nov 5.

Author

David Machado-Aranda¹

Affiliation

¹ Department of Surgery, University of Michigan, Ann Arbor, MI, USA, 48104. Electronic address: dmachad@med.umich.edu.

PMID: 31704418
DOI: 10.1016/j.ijsu.2019.10.038

No abstract available

Keywords: Hepatocellular Carcinoma; Living Donor Liver Transplantation; Positron Emission Tomography; Prognosis.

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Hepatocellular*
Fluorodeoxyglucose F18
Humans
Liver Neoplasms*
Liver Transplantation*
Living Donors
Patient Selection
Positron-Emission Tomography
Retrospective Studies
Transplant Recipients

Substances

Fluorodeoxyglucose F18